[Facial paralysis after temporal bone trauma]

Ann Otolaryngol Chir Cervicofac. 2006 Feb;123(1):9-16. doi: 10.1016/s0003-438x(06)76633-6.
[Article in French]

Abstract

Objectives: To evaluate functional outcome in 64 cases of facial paralysis following temporal bone fracture and discuss decisive arguments leading either to medical treatment or surgical management.

Methods: Sixty-four patients suffering from post-traumatic facial paralysis were managed between 1995 and 2003: 38 (59%) were given medical treatment and 26 (41%) underwent surgery. A combined middle fossa and transmastoid approach was mostly used (58%). Electrophysiological testing and CT scan results were the main points of the decision algorithm.

Results: Electroneuromyography seems to be the most accurate exploration for guiding treatment. Good results (grades I to II on the House and Brackmann scale) were obtained in 63% of cases after medical management and in 39% of cases after surgical treatment. Grades III or IV were obtained in 13% of medically-treated patients and 42% of surgically-treated patients.

Conclusion: Management of facial paralysis following temporal bone fracture in accordance with electrophysiological testing (evoked EMG) together with CT scan findings enabled accurate indications for surgical treatment. A good grade I or II result can be expected after medical management. A grade III is at best reached after nerve anastomosis.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Audiometry / methods
  • Child
  • Combined Modality Therapy
  • Electromyography
  • Facial Paralysis / diagnosis
  • Facial Paralysis / etiology*
  • Facial Paralysis / therapy
  • Female
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Prednisone / therapeutic use
  • Temporal Bone / injuries*
  • Temporal Bone / surgery
  • Tomography, X-Ray Computed
  • Wounds and Injuries / complications
  • Wounds and Injuries / therapy

Substances

  • Anti-Inflammatory Agents
  • Prednisone
  • Methylprednisolone